ES465872A1 - 1-phenoxy-3-t-butylaminopropan-2-ols - Google Patents

1-phenoxy-3-t-butylaminopropan-2-ols

Info

Publication number
ES465872A1
ES465872A1 ES465872A ES465872A ES465872A1 ES 465872 A1 ES465872 A1 ES 465872A1 ES 465872 A ES465872 A ES 465872A ES 465872 A ES465872 A ES 465872A ES 465872 A1 ES465872 A1 ES 465872A1
Authority
ES
Spain
Prior art keywords
formula
compound
platelet aggregation
relates
butylaminopropan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES465872A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr L Zambeletti SpA
Original Assignee
Dr L Zambeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr L Zambeletti SpA filed Critical Dr L Zambeletti SpA
Publication of ES465872A1 publication Critical patent/ES465872A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to 1- (2-nitro-methhenoxy) -3-t-butylamino-propan-2-ol of formula (I) ** (Formula) ** Where the CH3 moiety can be attached to the 3 05 positions of the benzene ring, and its physiologically acceptable salts. The invention also relates to a method for the preparation of compound (I) and to pharmaceutical compositions with platelet aggregation inhibitory activity, containing as an active principle the compound of formula (I). It has now surprisingly been found that the compounds of formula (I) can inhibit platelet aggregation, and consequently thrombus formation, in such a way as to allow the compound to be used in the prevention and therapy of thrombosis. (Machine-translation by Google Translate, not legally binding)
ES465872A 1977-01-12 1978-01-10 1-phenoxy-3-t-butylaminopropan-2-ols Expired ES465872A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT4100177 1977-01-12

Publications (1)

Publication Number Publication Date
ES465872A1 true ES465872A1 (en) 1979-01-01

Family

ID=11249971

Family Applications (1)

Application Number Title Priority Date Filing Date
ES465872A Expired ES465872A1 (en) 1977-01-12 1978-01-10 1-phenoxy-3-t-butylaminopropan-2-ols

Country Status (8)

Country Link
JP (1) JPS53111023A (en)
AT (1) ATA20678A (en)
BE (1) BE862680A (en)
DE (1) DE2758868A1 (en)
ES (1) ES465872A1 (en)
FR (1) FR2377372A1 (en)
GB (1) GB1563469A (en)
NL (1) NL7800215A (en)

Also Published As

Publication number Publication date
DE2758868A1 (en) 1978-07-13
JPS53111023A (en) 1978-09-28
NL7800215A (en) 1978-07-14
GB1563469A (en) 1980-03-26
BE862680A (en) 1978-05-02
FR2377372A1 (en) 1978-08-11
ATA20678A (en) 1979-01-15

Similar Documents

Publication Publication Date Title
GB2071088B (en) Indane derivatives
IE45256L (en) Quinazolone derivatives
ES2044836T3 (en) DERIVED FROM PIPERIDINE, ITS USE AND PHARMACEUTICAL COMPOUND CONTAINING IT.
NZ208529A (en) 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions
DK607783D0 (en) NITROALIPHATIC COMPOUNDS
ES425514A1 (en) Coumarin derivatives for the treatment of allergies
ES433860A1 (en) 3-(4{40 -Alkoxy-benzoyl)-1,2,2-trimethylcyclopentane-carboxylic acids, methods of use and compositions containing such compounds
ES8206455A1 (en) Guanidine derivatives and pharmaceutical compositions containing them.
JPS5646810A (en) Blood platelet coagulation inhibitor
ES400452A1 (en) Plant growth regulant compositions containing 2-haloethanesulphinic acid compounds
GB1169945A (en) Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
ES8103112A1 (en) Pseudotrisaccharides, their preparation and use as medicaments.
ES8407009A1 (en) (-)-15-Deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same.
ES465872A1 (en) 1-phenoxy-3-t-butylaminopropan-2-ols
ES368955A1 (en) Procedure for preparing substitute guanidines. (Machine-translation by Google Translate, not legally binding)
ES543802A0 (en) PROCEDURE FOR THE PREPARATION OF NEW A-ETILBEN-ZOL DERIVATIVES WITH A SUBSTITUTED N-CARBAMILOXY GROUP
ES466239A1 (en) Azacycloalkanes azacycloalkenes and derivatives thereof
FR2355846A1 (en) PENICILLIN ESTERS FOR USE AS MEDICINAL PRODUCTS
IT8024152A0 (en) DERIVATIVES OF 1,1,2-TRIFENYLPROPANE AND 1,1,2-TRIFENYLPROPENE, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS
FI862636A (en) PHARMACEUTICAL COMPOSITES WITH NEUROLEPTIC EFFECTS FOR FRUIT FRAMSTAELLNING.
FR2354762A1 (en) PRODUCTS AND COMPOSITIONS TO FIGHT AGAINST ALCOHOLISM
ES8304923A1 (en) New peptide, process for preparation thereof and pharmaceutical composition containing it.
ES471125A1 (en) 1-Substituted aminoindolines, process for their production and pharmaceutical compositions containing them.
FR2398499A1 (en) NEW PHARMACEUTICAL COMPOSITIONS BASED ON IMIDAZOLE DERIVATIVES TO INHIBIT THE SECRETION OF PROLACTIN
FR2449680A1 (en) PROSTAGLANDIN I2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM